During the past decade, Pulmonary Consultants conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 7 clinical trials were completed, i.e. on average, 700% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Pulmonary Consultants" #1 sponsor was "Allergy Therapeutics" with 1 trials, followed by "Boston Scientific Corporation" with 1 trials sponsored, "Daiichi Sankyo, Inc." with 1 trials sponsored, "Gilead Sciences" with 1 trials sponsored and "Hoffmann-La Roche" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

According to Clinical.Site data, the most researched conditions in "Pulmonary Consultants" are "Asthma" (2 trials), "Chronic Obstructive Pulmonary Disease" (2 trials), "Bronchiectasis" (1 trials), "COPD" (1 trials) and "Cachexia" (1 trials). Many other conditions were trialed in "Pulmonary Consultants" in a lesser frequency.

Most popular intervention types in "Pulmonary Consultants" are "Drug" (7 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "AZLI" (1 trials), "Alair System" (1 trials), "Lebrikizumab" (1 trials) and "Pirfenidone" (1 trials). Other intervention names were less common.

The vast majority of trials in "Pulmonary Consultants" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Pulmonary Consultants". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Pulmonary Consultants, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Pulmonary Consultants, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".